Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis

Vivek Subbiah; Razelle Kurzrock

doi:10.1200/JCO.22.02833

Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis

Vivek Subbiah, Razelle Kurzrock

Investigational Cancer Therapeutics

Research output: Contribution to journal › Comment/debate › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	3100-3103
Number of pages	4
Journal	Journal of Clinical Oncology
Volume	41
Issue number	17
DOIs	https://doi.org/10.1200/JCO.22.02833
State	Published - Jun 10 2023

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.22.02833

Cite this

@article{1ab3fe670c8841969a83bb0f2c4db06b,

title = "Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis",

author = "Vivek Subbiah and Razelle Kurzrock",

note = "Funding Information: V.S. is supported by a US National Institutes of Health (NIH; grant No. R01CA242845 and R01CA273168). The MD Anderson Cancer Center Department of Investigational Cancer Therapeutics is supported by the Cancer Prevention and Research Institute of Texas (RP1100584), the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (1U01 CA180964), NCATS Grant UL1 TR000371 (Center for Clinical and Translational Sciences), and the MD Anderson Cancer Center Support Grant (P30 CA016672).",

year = "2023",

month = jun,

day = "10",

doi = "10.1200/JCO.22.02833",

language = "English (US)",

volume = "41",

pages = "3100--3103",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "17",

}

TY - JOUR

T1 - Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer

T2 - Genomics Is the Diagnosis

AU - Subbiah, Vivek

AU - Kurzrock, Razelle

N1 - Funding Information: V.S. is supported by a US National Institutes of Health (NIH; grant No. R01CA242845 and R01CA273168). The MD Anderson Cancer Center Department of Investigational Cancer Therapeutics is supported by the Cancer Prevention and Research Institute of Texas (RP1100584), the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (1U01 CA180964), NCATS Grant UL1 TR000371 (Center for Clinical and Translational Sciences), and the MD Anderson Cancer Center Support Grant (P30 CA016672).

PY - 2023/6/10

Y1 - 2023/6/10

UR - http://www.scopus.com/inward/record.url?scp=85162949480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85162949480&partnerID=8YFLogxK

U2 - 10.1200/JCO.22.02833

DO - 10.1200/JCO.22.02833

M3 - Comment/debate

C2 - 36930859

AN - SCOPUS:85162949480

SN - 0732-183X

VL - 41

SP - 3100

EP - 3103

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 17

ER -

Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this